Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04822467 · ClinicalTrials.gov registry record · NA
SQ53 Disinfectant Wipes for Prevention of CRBSI
A NA study of Catheter-related Bloodstream Infection, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT04822467 is a NA study of Catheter-related Bloodstream Infection that has completed, run by The Cleveland Clinic. The registered enrollment target is 59 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04822467, a NA study of Catheter-related Bloodstream Infection, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
SQ53 is a novel antimicrobial, sporicidal solution that is based on a platform of quaternary ammonium chloride compounds. It has been tested against a wide range of bacteria, viruses, spores and fungal pathogens. Extensive laboratory testing has demonstrated the effectiveness of SQ53 impregnated wipes in cleaning surfaces including catheters over a 24 hour plus time period. SQ53 also received an in vitro evaluation of the irritancy potential using a tissue engineered human skin model and was found to have no potential for skin irritation. SQ53 is available as a sterilized pack with a single wipe inside. The pack is easy to open by tearing off the top end and presenting the contents to the operator to remove under sterile conditions. The current study will be a randomized single-blinded placebo-controlled clinical trial for SQ53 wipes intended for catheter cleaning in patients receiving home parenteral nutrition.
Conditions Studied
Interventions
- DEVICE SQ53 Wipe
- DEVICE Ethanol Wipe
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2021-12-10 |
| Est. Completion | 2022-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04822467
The ClinicalTrials.gov registry entry for NCT04822467 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Catheter-related Bloodstream Infection appearing as the primary indexed condition, and to 2 interventions - of which SQ53 Wipe is the first listed.
NCT04822467 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04822467 about?
NCT04822467 is a clinical study titled "SQ53 Disinfectant Wipes for Prevention of CRBSI". SQ53 is a novel antimicrobial, sporicidal solution that is based on a platform of quaternary ammonium chloride compounds. It has been tested against a wide range of bacteria, viruses, spores and fungal pathogens. Extensive laboratory testing has demonstrated the effectiveness of SQ53 impregnated wip...
What is the current status of trial NCT04822467?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2021-12-10. Estimated completion is 2022-12-07.
What conditions does trial NCT04822467 study?
This clinical trial studies the following conditions: Catheter-related Bloodstream Infection.
What interventions are being tested in trial NCT04822467?
The interventions under investigation include: SQ53 Wipe (DEVICE), Ethanol Wipe (DEVICE).
Who is sponsoring clinical trial NCT04822467?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04822467 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.